SCHEMBL24010367

SCHEMBL24010367

O=C(c1cccc(Nc2ccncc2)c1)N1CCc2ccc(Oc3ccncc3)cc21

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 1/20 0.42
GAA P10253 1/20 0.42
HTT P42858 1/20 0.42
CYP11B2 P19099 2/20 0.41
CYP11B1 P15538 1/20 0.41
HTR2C P28335 3/20 0.41
HTR2A P28223 2/20 0.41
RAB9A P51151 3/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
LMNA P02545 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
XIAP P98170 1/20 0.38
FAAH O00519 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25820810 0.96 FAAH (0.43) STAT3GAAHTTCYP11B2CYP11B1
SCHEMBL24010366 0.92 CYP11B2 (0.40) STAT3GAAHTTCYP11B2CYP11B1
SCHEMBL25820812 0.85 MEN1 (0.43) GAAHTTCYP11B2CYP11B1RAB9A
SCHEMBL25827157 0.83 HTR2C (0.40) STAT3GAAHTTCYP11B2CYP11B1
SCHEMBL24010376 0.81 LMNA (0.40) CYP11B2CYP11B1HTR2CHTR2ARAB9A
SCHEMBL24010133 0.81 STAT3 (0.44) STAT3GAAHTTCYP11B2CYP11B1
SCHEMBL25820804 0.79 UCHL1 (0.45) STAT3GAAHTTCYP11B2CYP11B1
SCHEMBL25822237 0.77 LMNA (0.45) HTR2CRAB9ALMNAALDH1A1HPGD
SCHEMBL30290895 0.76 DNMT1 (0.44) GAAHTTKMT2AALDH1A1XIAP
SCHEMBL24010132 0.76 DNMT1 (0.44) GAAHTTKMT2AALDH1A1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed
WO-2023081854-A1 AKT3 MODULATORS GEORGIAMUNE LLC (US) 2023-05-11 WO disclosed
WO-2021226458-A1 AKT3 MODULATORS GEORGIAMUNE LLC (US) 2021-11-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA STAT3 365/4885GAA 1228/4885HTT 3124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.